Loading…

Multifunctional Nanocarriers for Lung Drug Delivery

Nanocarriers have been increasingly proposed for lung drug delivery applications. The strategy of combining the intrinsic and more general advantages of the nanostructures with specificities that improve the therapeutic outcomes of particular clinical situations is frequent. These include the surfac...

Full description

Saved in:
Bibliographic Details
Published in:Nanomaterials (Basel, Switzerland) Switzerland), 2020-01, Vol.10 (2), p.183
Main Authors: Pontes, Jorge F, Grenha, Ana
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c450t-8e04ca6e8c948c360c5fb37c54ac23b2f6fd37a93f5cad0bac9cf2f97cf16b203
cites cdi_FETCH-LOGICAL-c450t-8e04ca6e8c948c360c5fb37c54ac23b2f6fd37a93f5cad0bac9cf2f97cf16b203
container_end_page
container_issue 2
container_start_page 183
container_title Nanomaterials (Basel, Switzerland)
container_volume 10
creator Pontes, Jorge F
Grenha, Ana
description Nanocarriers have been increasingly proposed for lung drug delivery applications. The strategy of combining the intrinsic and more general advantages of the nanostructures with specificities that improve the therapeutic outcomes of particular clinical situations is frequent. These include the surface engineering of the carriers by means of altering the material structure (i.e., chemical modifications), the addition of specific ligands so that predefined targets are reached, or even the tuning of the carrier properties to respond to specific stimuli. The devised strategies are mainly directed at three distinct areas of lung drug delivery, encompassing the delivery of proteins and protein-based materials, either for local or systemic application, the delivery of antibiotics, and the delivery of anticancer drugs-the latter two comprising local delivery approaches. This review addresses the applications of nanocarriers aimed at lung drug delivery of active biological and pharmaceutical ingredients, focusing with particular interest on nanocarriers that exhibit multifunctional properties. A final section addresses the expectations regarding the future use of nanocarriers in the area.
doi_str_mv 10.3390/nano10020183
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9d2b6b6bb9604ac5ad528a1dcaf9e2a8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9d2b6b6bb9604ac5ad528a1dcaf9e2a8</doaj_id><sourcerecordid>2344275448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-8e04ca6e8c948c360c5fb37c54ac23b2f6fd37a93f5cad0bac9cf2f97cf16b203</originalsourceid><addsrcrecordid>eNpVkc1LAzEQxYMoKtqbZ-nRg9V8bjYXQfyGqhc9h9nZpEa2G012C_73bq1KO4GZkDx-b-ARcsTomRCGnrfQRkYpp6wUW2SfU20m0hi2vXbfI6Oc3-lQholSiV2yJ5jRgiq2T8Rj33TB9y12IbbQjJ8GIkJKwaU89jGNp307G1-nfmiuCQuXvg7Jjocmu9HvPCCvtzcvV_eT6fPdw9XldIJS0W5SOioRCleikSWKgqLyldCoJCAXFfeFr4UGI7xCqGkFaNBzbzR6VlScigPysOLWEd7tRwpzSF82QrA_DzHNLKQuYOOsqXlVDKcyBR3wCmrFS2A1gjeOQzmwLlasj76auxpd2yVoNqCbP214s7O4sJpqWerlMie_gBQ_e5c7Ow8ZXdNA62KfLRdScq2kXHqdrqSYYs7J-X8bRu0yNrse2yA_Xl_tX_wXkvgGiV2U2A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2344275448</pqid></control><display><type>article</type><title>Multifunctional Nanocarriers for Lung Drug Delivery</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Pontes, Jorge F ; Grenha, Ana</creator><creatorcontrib>Pontes, Jorge F ; Grenha, Ana</creatorcontrib><description>Nanocarriers have been increasingly proposed for lung drug delivery applications. The strategy of combining the intrinsic and more general advantages of the nanostructures with specificities that improve the therapeutic outcomes of particular clinical situations is frequent. These include the surface engineering of the carriers by means of altering the material structure (i.e., chemical modifications), the addition of specific ligands so that predefined targets are reached, or even the tuning of the carrier properties to respond to specific stimuli. The devised strategies are mainly directed at three distinct areas of lung drug delivery, encompassing the delivery of proteins and protein-based materials, either for local or systemic application, the delivery of antibiotics, and the delivery of anticancer drugs-the latter two comprising local delivery approaches. This review addresses the applications of nanocarriers aimed at lung drug delivery of active biological and pharmaceutical ingredients, focusing with particular interest on nanocarriers that exhibit multifunctional properties. A final section addresses the expectations regarding the future use of nanocarriers in the area.</description><identifier>ISSN: 2079-4991</identifier><identifier>EISSN: 2079-4991</identifier><identifier>DOI: 10.3390/nano10020183</identifier><identifier>PMID: 31973051</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><subject>antibiotics ; cancer ; drug delivery ; lung delivery ; nanocarriers ; nanopharmaceuticals ; proteins ; Review</subject><ispartof>Nanomaterials (Basel, Switzerland), 2020-01, Vol.10 (2), p.183</ispartof><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-8e04ca6e8c948c360c5fb37c54ac23b2f6fd37a93f5cad0bac9cf2f97cf16b203</citedby><cites>FETCH-LOGICAL-c450t-8e04ca6e8c948c360c5fb37c54ac23b2f6fd37a93f5cad0bac9cf2f97cf16b203</cites><orcidid>0000-0002-2136-1396 ; 0000-0002-6447-0242</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074870/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074870/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31973051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pontes, Jorge F</creatorcontrib><creatorcontrib>Grenha, Ana</creatorcontrib><title>Multifunctional Nanocarriers for Lung Drug Delivery</title><title>Nanomaterials (Basel, Switzerland)</title><addtitle>Nanomaterials (Basel)</addtitle><description>Nanocarriers have been increasingly proposed for lung drug delivery applications. The strategy of combining the intrinsic and more general advantages of the nanostructures with specificities that improve the therapeutic outcomes of particular clinical situations is frequent. These include the surface engineering of the carriers by means of altering the material structure (i.e., chemical modifications), the addition of specific ligands so that predefined targets are reached, or even the tuning of the carrier properties to respond to specific stimuli. The devised strategies are mainly directed at three distinct areas of lung drug delivery, encompassing the delivery of proteins and protein-based materials, either for local or systemic application, the delivery of antibiotics, and the delivery of anticancer drugs-the latter two comprising local delivery approaches. This review addresses the applications of nanocarriers aimed at lung drug delivery of active biological and pharmaceutical ingredients, focusing with particular interest on nanocarriers that exhibit multifunctional properties. A final section addresses the expectations regarding the future use of nanocarriers in the area.</description><subject>antibiotics</subject><subject>cancer</subject><subject>drug delivery</subject><subject>lung delivery</subject><subject>nanocarriers</subject><subject>nanopharmaceuticals</subject><subject>proteins</subject><subject>Review</subject><issn>2079-4991</issn><issn>2079-4991</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkc1LAzEQxYMoKtqbZ-nRg9V8bjYXQfyGqhc9h9nZpEa2G012C_73bq1KO4GZkDx-b-ARcsTomRCGnrfQRkYpp6wUW2SfU20m0hi2vXbfI6Oc3-lQholSiV2yJ5jRgiq2T8Rj33TB9y12IbbQjJ8GIkJKwaU89jGNp307G1-nfmiuCQuXvg7Jjocmu9HvPCCvtzcvV_eT6fPdw9XldIJS0W5SOioRCleikSWKgqLyldCoJCAXFfeFr4UGI7xCqGkFaNBzbzR6VlScigPysOLWEd7tRwpzSF82QrA_DzHNLKQuYOOsqXlVDKcyBR3wCmrFS2A1gjeOQzmwLlasj76auxpd2yVoNqCbP214s7O4sJpqWerlMie_gBQ_e5c7Ow8ZXdNA62KfLRdScq2kXHqdrqSYYs7J-X8bRu0yNrse2yA_Xl_tX_wXkvgGiV2U2A</recordid><startdate>20200121</startdate><enddate>20200121</enddate><creator>Pontes, Jorge F</creator><creator>Grenha, Ana</creator><general>MDPI</general><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2136-1396</orcidid><orcidid>https://orcid.org/0000-0002-6447-0242</orcidid></search><sort><creationdate>20200121</creationdate><title>Multifunctional Nanocarriers for Lung Drug Delivery</title><author>Pontes, Jorge F ; Grenha, Ana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-8e04ca6e8c948c360c5fb37c54ac23b2f6fd37a93f5cad0bac9cf2f97cf16b203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>antibiotics</topic><topic>cancer</topic><topic>drug delivery</topic><topic>lung delivery</topic><topic>nanocarriers</topic><topic>nanopharmaceuticals</topic><topic>proteins</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pontes, Jorge F</creatorcontrib><creatorcontrib>Grenha, Ana</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Nanomaterials (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pontes, Jorge F</au><au>Grenha, Ana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multifunctional Nanocarriers for Lung Drug Delivery</atitle><jtitle>Nanomaterials (Basel, Switzerland)</jtitle><addtitle>Nanomaterials (Basel)</addtitle><date>2020-01-21</date><risdate>2020</risdate><volume>10</volume><issue>2</issue><spage>183</spage><pages>183-</pages><issn>2079-4991</issn><eissn>2079-4991</eissn><abstract>Nanocarriers have been increasingly proposed for lung drug delivery applications. The strategy of combining the intrinsic and more general advantages of the nanostructures with specificities that improve the therapeutic outcomes of particular clinical situations is frequent. These include the surface engineering of the carriers by means of altering the material structure (i.e., chemical modifications), the addition of specific ligands so that predefined targets are reached, or even the tuning of the carrier properties to respond to specific stimuli. The devised strategies are mainly directed at three distinct areas of lung drug delivery, encompassing the delivery of proteins and protein-based materials, either for local or systemic application, the delivery of antibiotics, and the delivery of anticancer drugs-the latter two comprising local delivery approaches. This review addresses the applications of nanocarriers aimed at lung drug delivery of active biological and pharmaceutical ingredients, focusing with particular interest on nanocarriers that exhibit multifunctional properties. A final section addresses the expectations regarding the future use of nanocarriers in the area.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>31973051</pmid><doi>10.3390/nano10020183</doi><orcidid>https://orcid.org/0000-0002-2136-1396</orcidid><orcidid>https://orcid.org/0000-0002-6447-0242</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2079-4991
ispartof Nanomaterials (Basel, Switzerland), 2020-01, Vol.10 (2), p.183
issn 2079-4991
2079-4991
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9d2b6b6bb9604ac5ad528a1dcaf9e2a8
source Publicly Available Content Database; PubMed Central
subjects antibiotics
cancer
drug delivery
lung delivery
nanocarriers
nanopharmaceuticals
proteins
Review
title Multifunctional Nanocarriers for Lung Drug Delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T01%3A24%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multifunctional%20Nanocarriers%20for%20Lung%20Drug%20Delivery&rft.jtitle=Nanomaterials%20(Basel,%20Switzerland)&rft.au=Pontes,%20Jorge%20F&rft.date=2020-01-21&rft.volume=10&rft.issue=2&rft.spage=183&rft.pages=183-&rft.issn=2079-4991&rft.eissn=2079-4991&rft_id=info:doi/10.3390/nano10020183&rft_dat=%3Cproquest_doaj_%3E2344275448%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-8e04ca6e8c948c360c5fb37c54ac23b2f6fd37a93f5cad0bac9cf2f97cf16b203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2344275448&rft_id=info:pmid/31973051&rfr_iscdi=true